As the world of medicine accelerates, Clinical Trials are facing considerable challenges. A startling 30% of patients drop out, overwhelmed by complex medical protocols, multiple devices, burdensome schedules, poor communication, and a pervasive sense of being undervalued. With costs mounting between 20-100K USD per patient, and delays potentially accruing between 600 k - 8 million USD daily, the system is strained. Enter THEMISON: A pioneering SaaS patient-centric platform pioneering the concept of Patient Success, akin to Customer Success in the SaaS world. Our mission is to enhance engagement, simplify trial complexities, make patients feel valued, and dramatically reduce dropout rates. By seamlessly integrating with existing tools and delivering real-time analytics, we provide pharmaceuticals an unparalleled insight into patient engagement, so they can step in when needed to prevent dropouts. By bridging the gap between patient experience, integrations, and insightful analytics, THEMISON stands to improve the clinical trial landscape.Something looks off?